Zinacef
Active Ingredient(s): CefuroximeFDA Approved: * October 19, 1983
Pharm Company: * GLAXOSMITHKLINE
Category: Antibiotics
Cefuroxime, sold under the brand name Zinacef among others, is a second-generation cephalosporin[1] antibiotic used to treat and prevent a number of bacterial infections.[2] These include pneumonia, meningitis, otitis media, sepsis, urinary tract infections, and Lyme disease.[3] It is used by mouth or by injection into a vein or muscle.[3] Common side effects include nausea, diarrhea, allergic reactions, and pain at the site of i... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Zinacef 1.5 g/16ml Intravenous Injection, Powder, for Solution
NDC: 0173-0354
Labeler:
Glaxosmithkline LLC
Zinacef 750 mg/8.3ml Intravenous Injection, Powder, for Solution
NDC: 0173-0436
Labeler:
Glaxosmithkline LLC
Zinacef 1.5 g/16ml Intravenous Injection, Powder, for Solution
NDC: 0173-0437
Labeler:
Glaxosmithkline LLC
Zinacef 90 mg/ml Intramuscular; Intravenous Injection, Powder, for Solution
NDC: 24987-352
Labeler:
Covis Pharmaceuticals Inc
Zinacef 90 mg/ml Intravenous Injection, Powder, for Solution
NDC: 24987-354
Labeler:
Covis Pharmaceuticals Inc
Zinacef 90 mg/ml Intravenous Injection, Powder, for Solution
NDC: 24987-400
Labeler:
Covis Pharmaceuticals Inc
Zinacef 1.5 g/50ml Intravenous Injection, Solution
NDC: 24987-425
Labeler:
Covis Pharmaceuticals Inc
Zinacef 90 mg/ml Intravenous Injection, Powder, for Solution
NDC: 24987-436
Labeler:
Covis Pharmaceuticals Inc
Zinacef 90 mg/ml Intravenous Injection, Powder, for Solution
NDC: 24987-437
Labeler:
Covis Pharmaceuticals Inc